Approved Study Database

Ref. No. Scientific Title Principal investigator
2013.385 Maternal antenatal antithyroid medication exposure and fetal congenital abnormality TING Yuen Ha
2005.174 Sequencing Analysis of 3' Region of cagA Gene in Helicobacter Pylori Isolated from Hong Kong Chinese Patients with Different H. Pylori-associated Diseases TO Ka Fai
2005.129 Epigenetic Silencing of DOC2-hDAB2 and Tumor Suppressor Activity of DOC2-hDAB2 in Nasopharyngeal Carcinoma TO Ka Fai
2004.152 Characterization of Epstein Barr Virus Status and Genetic Alterations in Squamous Cell Carcinoma of Nasopharynx and Other Head and Neck Regions TO Ka Fai
2004.154 Identification of Human Cell Line Model of Persistent Coronavirus (SARS-CoV) Infection and Studies in the Cytokines and Chemokines Response TO Ka Fai
2006.133 Epigenetic Silencing of CXCL14 and Its in Vitro/in Vivo Modulation of Dendritic Cell in Nasopharyngeal Carcinoma TO Ka Fai
2005.405 Centre for MicroRNA Study - Basic Research and Clinical Applications in Nasopharyngeal Cancer and Liver Cancer TO Ka Fai
2007.257 Identification and Characterization of a Novel Epstein-Barr Virus microRNAs (ebv-miRNA) in Nasopharyngeal Carcinoma Cells TO Ka Fai
2006.385 Research Centre for Gastric Cancer Epigenetics: Molecular Basis and Clinical Applications TO Ka Fai
2006.278 Identification of Epstein-Barr Virus miRNA in Nasopharyngeal Carcinoma Cells TO Ka Fai
2008.544 Epigenetic regulation of the multidrug resistance transporter ABCG2 in human normal and cancer cells with a range of ABCG2 expression levels TO Kin Wah
2006.404 Evaluation of New Diagnostic and Treatment Algorithm for Obstructive Sleep Apnea in High Risk Population in Hong Kong Dr. To Kin Wang
2005.399 Effect of Endoscopic Gastric Balloon Insertion on Obstructive Sleep Apnea in Patients with Morbid Obesity TO Kin Wang
2004.258 Comparison of Auto-Continuous Positive Airway Pressure Device (Auto-CPAP) with Conventional Fixed CPAP in Chinese Patients with Obstructive Sleep Apnea (OSA) Dr. To Kin Wang
2011.243 Defining nasal respiratory tissue biomarkers for diagnosis and monitoring of latent TB in patients with rheumatological diseases. (cross sectional study, with reference to interferon-gamma release assay) TO Kin Wang
2005.119 Middle Cerbral Artery Stenosis and other Cardiovascular Risk Factors in the Prediction of Mortality from Cardiovascular and other Disease TOMLINSON Brian
2004.088 Genetic Determinants of Response to Blood Pressure-Lowering Therapies TOMLINSON Brian
2010.050 A Bioequivalence Study of Acarbose following FDA Guidance Prof. Tomlinson Brian
2010.055 A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Safety Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus Treated With Dutogliptin Prof. Tomlinson Brian
2007.392 Study of Phenotype and Genotype of Normotensive and Pre-hypertensive Chinese with or without Family History TOMLINSON Brian
2010.117 Urinary excretion of cortisol and its metabolites: Diurnal pattern and effects of herbs products. Prof. Tomlinson Brian
2010.054 Effects of 150 _g aleglitazar on renal function in patients with Type 2 diabetes and moderate renal impairment, as compared to Actos Prof. Tomlinson Brian
2006.282 TRENDY - Experience with A Lipid Triad Modifying Drug Niaspan (Prolonged Release Micotinic Acid) in Hong Kong Patients with Dyslipidemia - A Hong Kong Post-Marketing Survelliance Study on Prolonged Release Nicotinic Acid (Niaspan) In Patients with High Ca TOMLINSON Brian
2006.462 Pharmacokinetics of Single and Repeated Oral Administration of S 33138 20 mg Daily in Chinese Healthy Male and Female Volunteers Prof. Tomlinson Brian
2001.453 The Evaluation Of Tissue Link Floating Ball For Hemostasis In Patients Undergoing Tonsillectomy Prof. Tong C F Michael
2006.057 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin in Combination with Glyburide in Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control on Glyburide Alone Prof. Tong C.Y. Peter
2007.138 A 16 Week Open-Label Outpatient, Randomized, Parallel Study Assessing the Impact of Two Different Initial Dose Prescriptions for Dry Powder Inhaled Insulin (EXUBERA_) on Glycemic Control in Patients with Type 2 Diabetes Mellitus Who are Poorly Controlled on A Combination of Two or More Oral Agents Prof. Tong C.Y. Peter
2007.052 Clinical Trial of HiRes_ 120 and Auria+ Prof. Tong CF Michael
2002.396 An Open, Randomised, Comparative, Multicentre Phase IIIb-IV Trial of the Efficacy and Safety of Ketek (Telithromycin) 8000mg Once Daily Versus other Usually Prescribed Anti-bacterials in Treating Outpatients with Mild to Moderate Community Acquired Pneumonia, Acute Exacerbations of Chronic Bronchitis and Acute Sinusitis Prof. Tong CF Michael
2006.299 Self-Perceived Swallowing Difficulties in Nasopharyngeal Cancer Survivors: A Qualitative Sutdy TONG CF Michael
2005.081 Assessing Quality of Life in Patients with Nasopharyngeal Carcinoma Using a Newly Developed Disease-Specific Instrument: A Multicentre Study TONG CF Michael
2007.051 Perceptural Channels Using Current Steering in Cochlear Implang TONG CF Michael
2005.064 A Study on Dysphagia in Patients with Nasopharyngeal Carcinoma Post-Radiotherapy: The Diagnosis, Use of Investigations and Surgical Intervention TONG Chi Fai Michael
2006.449 The Importance of Slow-Varying Temporal Information (Temporal Envelope) for Speech Recognition in Tonal Languages - Implications for the Design of New Hearing Aid Algorithms TONG Chi Fai Michael
2006.107 Childhood Dysphonia among School Aged Children in Hong Kong TONG Chi Fai Michael
2007.333 Clinical Trial for the Hybrid Cochlear Implant System for Tonal Language Speech Recognition in Cantonese TONG Chi Fai Michael
2007.291 Cohort Study of a 2-Stage Universal Neonatal Hearing Screening Program in Local Hospitals TONG Chi Fai Michael
2005.420 A Study of Otitis Media with Effusion in Schoolchildren in Hong Kong TONG Chi Fai Michael
2006.251 A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin (MK-0431) in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy with Metformin and A PPARy Agonist Prof. Tong Chun Yip Peter
2005.146 A Randomised, Double-Blind, Placebo-Controlled Study of Cilostazol 100mg Twice Daily in the Treatment of Diabetic Nephropathy in Hong Kong Chinese Prof. Tong Chun Yip Peter
2006.249 An Open Label Study to Assess the Efficacy of Losartan/HCTZ Combination Therapy in Patients with Essential Hypertension Who Were Inadequately Controlled on Current Antihypertensive Monotherapy Prof. Tong Chun Yip Peter
2007.329 A Proof-of-Concept Study of Darbepoetin Alfa in the Partial Correction of Anaemia in Hong Kong Chinese with Diabetes Mellitus and Chronic Kidney Disease Prof. Tong Chun Yip Peter
2007.036 An Open Label Tolerability and Safety Study of KRX-101 (Sulodexide Gelcaps) for the Treatment of Type 2 Diabetic Nephropathic Patients with Persistent Microalbuminuria in Australia, New Zealand, and Hong Kong Prof. Tong Chun Yip Peter
2003.092 Oxidative Stress and Insulin Resistance in Hong Kong Chinese with Thalassaemia Minor TONG Chun Yip Peter
2002.087 The Participation of the Cytoskeleton in Insulin Action in Human Skeletal Muscle TONG Chun Yip Peter
2005.392 Diabetes, Insulin Resistance and Chronic Inflammation in Hong Kong Chinese Patients with Tuberculosis TONG CY Peter
2007.255 Association of Glomerulopathy with the Polymorphisms of Aldose Reductase Gene and apoE Gene for Nephropathy in Type 2 Diabetes Mellitus TONG CY Peter
2004.263 A Phase 3, Randomized, Three-Arm, Double-blind, Active Controlled, Parallel Group, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar in Combination with Metformin Compared to Glimepiride in Combination with Metformin in Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone Prof. Tong CY Peter
2005.296 The Effect of Sulodexide in Patients with Type 2 Diabetes and Microalbuminuria Prof. Tong CY Peter
2007.328 The Evaluation of Chinese Medicine on Control of Metabolic Parameters and Quality of Life in Chinese Patients with Type 2 Diabetes TONG CY Peter

Page 37 of 254.